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Introduction: Increasing bacteria resistance to antibiotics is a major problem of healthcare
system. There is a need for solutions that broaden the spectrum of bactericidal agents
improving the efficacy of commonly used antibiotics. One of the promising directions of
search are silver nanoparticles (obtained by different methods and displaying diversified
physical and chemical properties), and their combination with antibiotics.
Purpose: In this study, we tested the role of reactive oxygen species in the mechanism of
synergistic antibacterial activity of gentamicin and Tween-stabilized silver nanoparticles
against gentamicin-resistant clinical strains of Staphylococcus epidermidis.
Methods: Synergistic bactericidal activity of gentamicin and silver nanoparticles stabilized with
non-ionic detergent (Tween 80) was tested by the checkerboard titration method on microtiter
plates. Detection of reactive oxygen species was based on the chemiluminescence of luminol.
Results: Hydrophilic non-ionic surface functionalization of silver nanoparticles enabled the
existence of non-aggregated active nanoparticles in a complex bacterial culture medium.
Tween-stabilized silver nanoparticles in combination with gentamicin exhibited bactericidal
activity against multidrug-resistant biofilm forming clinical strains of Staphylococcus epi-
dermidis. A synergistic effect significantly decreased the minimal inhibitory concentration of
gentamicin (the antibiotic with numerous undesirable effects). Gentamicin significantly
enhanced the generation of reactive oxygen species by silver nanoparticles.
Conclusion: Generation of reactive oxygen species by Tween-coated metallic silver nanoparti-
cles was significantly enhanced by gentamicin, confirming the hypothesis of oxidative-associated
mechanism of the synergistic antibacterial effect of the gentamicin-silver nanoparticles complex.
Keywords: gentamicin, silver nanoparticles, reactive oxygen species, multidrug-resistant,
Staphylococcus epidermidis
Introduction
Untargeted therapy as well as abuse of antibacterial drugs has led to the selection of
bacterial strains resistant to available antibiotics. Microorganisms resistant to many
different groups of antibiotics pose a particular danger.1 There is a need for alternative
agents to combat bacterial infections.2 New antibacterial compounds should be effective
in eradicatingmicroorganisms, easily accessible, cheap, harmless to the environment and,
above all, safe for the patient. Special interest is currently associated with nanomaterials,
including silver nanoparticles (SNPs), as well as their combination with antibiotics.3,4
The antibacterial properties of silver were known from ancient times. In ancient
Egypt, silver solutions were used to treat peptic ulcer disease. Food was stored in
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silver vessels for longer protection. Soldiers put silver
coins on the wounds, what accelerated the healing
process.5 Nowadays silver is widely used in medicine
(silver coating on implants and catheter tubes), cosmetol-
ogy, biotechnology, food and textile industries.6
The antibacterial properties of silver nanoparticles
depend primarily on their size, shape, surface modification
and concentration. The mechanism of bactericidal action
of SNPs has not been clearly explained. Under the influ-
ence of their action, the process of wall and cell membrane
formation is disturbed, protein synthesis is also inhibited.
Nanoparticles affect nucleic acids and cellular metabolic
processes. It is also assumed that the bactericidal effect
may result from the induction of the reactive oxygen
species (ROS) production by silver nanoparticles.7
Gentamicin and other antibiotics may form chemical
complexes by binding of the active hydroxyl or amine
group with metals. This may affect their biological
activity.8 The combination of silver nanoparticles with
antibiotics used in therapy may increase the bactericidal
activity of both nanoparticles and antibiotics, even in
relation to strains resistant to their action.9–13 The mechan-
ism leading to the increased bactericidal activity of the
drug-nanoparticle complex may be related to production of
reactive oxygen species by silver nanoparticles under the
influence of an antibiotic.14–16
Silver nanoparticles display diverse stability in complex
solutions such as media used in microbiological tests. In
order to provide adequate stability of SNPs, various types
of stabilizing agents are used, both ionic and non-ionic. In
this study Tween 80, non-ionic surfactant and emulgator,
was used as a silver nanoparticles stabilizing agent.17
We demonstrated synergistic antibacterial activity of gen-
tamicin and Tween-stabilized silver nanoparticles against
gentamicin resistant clinical strains of Staphylococcus epi-
dermidis. Antimicrobial activity of the Tween-stabilized sil-
ver nanoparticles was accompanied by production of reactive




Polysorbate 80 (Tween 80), silver nitrate, sodium borohy-
dride, luminol and gentamicin sulfate were purchased from
Sigma Aldrich Co. The Mueller-Hinton Broth II (Becton
Dickinson) was used as a microbiological medium. UV-
Vis spectra were recorded on Multiskan Sky Reader
(Thermo Scientific). For the incubation and horizontal
shaking of the microtiter plates containing bacterial cul-
tures ES-20 Shaker (Biosan, Poland) was used.
All of the tested strains of Staphylococcus epidermidis
were isolated from blood of newborns with low birth
weight and catheter-related sepsis. Blood was collected
during routine diagnostic tests, after obtaining written
informed parental consent. No additional blood sample
was taken, instead, the strains isolated in a hospital labora-
tory during routine diagnostic tests were used for the
purpose of the study. This study was approved by the
Bioethical Committee of the Jagiellonian University no.
KBET/263/B/2013.
Synthesis of Silver Nanoparticles
Tween-stabilized silver nanoparticles (diameter 20–40 nm
established by TEM - transmission electron microscopy)
were prepared by thermal reduction of silver nitrate by
Tween 80.18 Briefly, silver salt solution prepared by dissol-
ving 50 mg of AgNO3 in 0.2 mL of deionized water was
mixed with 2 mL of Tween 80 and incubated at 100°C for 72
hours. The color of reaction solution changed from yellow to
orange and in the end to dark red-brown. The basic working
solution of silver nanoparticles was prepared by 5x dilution
of the reaction mixture with deionized water. The molar
concentration of the working solution of SNPs was estimated
on the basis of the LSPR (Localized Surface Plasmon
Resonance) maximum and the molar extinction coefficient
(4.18 x 109 M–1 cm–1),19 to be 60 nM. The concentration of
metallic silver in the solution was 1400 µg/mL.
To address the problem of SNPs stability, citrate-
stabilized silver nanoparticles were used. Nanoparticles
were synthesized by reducing silver nitrate with sodium
borohydride in the presence of sodium citrate.20 Briefly,
0.5 mL of AgNO3 (0.01 M) was mixed with 19 mL of
sodium citrate (0.01 M). In the next step, 0.6 mL of sodium
borohydride (0.01 M) was added gradually. Reaction was
carried out at 0°C. The molar concentration of 10 nm SNPs
solution was estimated, on the basis of the LSPR maximum
and the molar extinction coefficient (5.56 x 108 M–1 cm–1)19
to be 10 nM.
The Assessment of Antimicrobial Activity
of Combination of Gentamicin and Silver
Nanoparticles
Nine multidrug-resistant (MDR) clinical strains of
Staphylococcus epidermidiswere isolated from blood cultures
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and stored at −80ºC until use. The drug resistance of the
isolates were confirmed according to the protocols of
European Committee on Antimicrobial Susceptibility Testing
(EUCAST).21
The minimal inhibitory concentration (MIC) values of
gentamicin for selected strains were assessed according to
the recommendations of EUCAST.22 The analogous test
was conducted to assess the antimicrobial activity of silver
nanoparticles.
To evaluate the MIC value of gentamicin in combination
with SNPs, the antimicrobial activity of antibiotic and silver
nanoparticles was investigated by checkerboard titration
method on 96-well microtiter plates.23 The checkerboard
method was based on microdilution assay. Briefly, 100 μL of
Mueller-Hinton Broth II (MHB II) was added to each well on
the plate, the dilutions of gentamicin (in range of 0.97 to 250
μg/mL) were made from left to the right side of the plate,
dilutions of SNPs (in range of 21.5 to 1400 μg/mL) weremade
from upper to lower rows of the plate. To microtiter wells,
containing different combinations of gentamicin and SNPs, 10
μL of 1.0 McFarland bacterial saline suspension was added.
The final concentration of bacteria in each well was 1.5 × 107
CFU/mL (colony-forming unit). To determine the microbial
growth inhibition the microtiter plates were incubated at 37°C
for 24 hours with horizontal shaking (120 rpm/min). To reduce
the SNPs related optical background of SNPs, after first incu-
bation, 10 μL of suspension from each well on the plate was
transferred to 190 μL of MHB II on another plate and incu-
bated at 37°C for 24 hours with horizontal shaking (120 rpm/
min). To assess the growth of the strains, the optical density of
the solutions was measured with microplate reader Sunrise
(Tecan, Switzerland) at wavelength 600 nm. The checkerboard
tests was performed for all of tested strains in duplicates. The
growth control and negative control were maintained during
the test. The growth control was maintained to confirm the
normal growth of the bacteria in test condition. Briefly, 10 µL
of 1.0McFarland bacterial saline suspension was added to 190
µL of MHB II. The negative control (200 µL of MHB II) was
maintained to confirm the purity of microbiological medium
and to prove lack of contamination of the solutions during the
test. Additional control was carried out to confirm that Tween
80, detergent used during the synthesis of SNPs, does not
show the bactericidal effect. Briefly, 100 µL of MHB II was
mixed with 100 µL of 20% v/v Tween 80 solution and 10 µL
of bacterial saline suspension.
The interpretation of the checkerboard test was based
on the value of a Fractional Inhibitory Concentration (FIC)
Index:24
FIC index ¼ MIC of gentamicimwith SNPs
MIC of gentamicin
þMIC of SNPswith gentamicin
MIC of SNPs
The FIC values have been interpreted as follows:
FIC ≤ 0.5 - synergistic effect
> 0.5 and ≤ 1 - additive effect
> 1 and <4 - no action
≥ 4 - antagonistic effect
The capability of tested strains to biofilm formation was
evaluated according to procedure of Christensen et al, based
on the assessment of bacterial cells’ adherence to 96-well
tissue culture plates. Bacterial saline suspension (1.0
McFarland) was incubated with the plate for 18 hours,
37ºC. After incubation, the suspension was removed and
wells were washed with phosphate-buffered saline.
Adherent cells were fixed and stained with 1% crystal violet
water solution. Interpretation of the test was based on the
value of optical density measured with microplate reader at
600 nm wavelength.25 The positive (Staphylococcus aureus
SA RN450) and negative control (Staphylococcus epidermi-
dis SE ATCC12228) were maintained during the test. Eight
of nine of the investigated strains of Staphylococcus epider-
midis displayed the ability to biofilm formation.
Detection of Reactive Oxygen Species
Detection of ROS was based on the chemiluminescence of
luminol.26 The generation of ROS was investigated by mixing
100 µL of luminol solution (5 mM in phosphate-buffered
saline) with 100 µL Tween-stabilized silver nanoparticles
(working solution was diluted 25x with deionized water) and
2 µL of gentamicin water solution (40 mg/mL) to obtain final
antibiotic concentration of 0.4 mg/mL. Chemiluminescence
wasmeasured on a LUMATLB 9507 (Berthold Technologies)
luminometer at 1-s intervals.
Results
Stability of SNP Solutions in the Presence of
Bacterial Growth Medium and Gentamicin
Silver nanoparticles require adequate stabilization to elimi-
nate precipitation in growth media due to the destabilization
of the surface charge of the molecules. Citrate-stabilized
silver nanoparticles precipitate in the broth, yielding dark
precipitate of metallic silver. The study compared the stabi-
lity of silver nanoparticles, both Tween and citrate-stabilized
in Mueller-Hinton Broth II.
Dovepress Mazur et al
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Figure 1 presents plasmon resonance related UV-Vis
spectrum of the solutions of Tween and citrate-stabilized
silver nanoparticles made with and without addition of
broth (1:1 volume ratio). Changes in the spectrum of
citrate-stabilized silver nanoparticles accompanied by
metallic silver precipitation in the presence of broth con-
firms instability of citrate-stabilized SNPs (Figure 1A).
Contrarily, Tween-stabilized silver nanoparticles are stable
in the presence of broth solution as confirmed by UV-Vis
spectrum of Tween-stabilized silver nanoparticles in
the presence of MHB II (Figure 1B).
Stability of SNPs may be affected by many physical
factors/reagents. Containing four amino groups, basic
molecules of gentamicin have enhanced affinity to citrate-
stabilized SNPs causing their massive aggregation and
precipitation.27 To the opposite, Tween-stabilized SNPs
are stable in the presence of gentamicin.
Changes in the spectrum of citrate-stabilized silver nano-
particles accompanied by metallic silver precipitation in the
presence of gentamicin are presented on the Figure 2A. UV-
Vis spectrum of Tween-stabilized silver nanoparticles in the
presence of gentamicin (Figure 2B) confirms that Tween-
stabilized silver nanoparticles are stable in that conditions.
The method of synthesis/stabilization plays a crucial role in
the biological activity of SNPs. Regarding the high stability
of Tween-stabilized SNPs and the lack of the pronounced
biological activity of the Tween itself, Tween-stabilized
silver nanoparticles were used in further experiments.
Antimicrobial Activity of Gentamicin in
the Presence of SNPs
Addition of SNPs strongly affected the minimal inhibitory
concentration of gentamicin for all gentamicin resistant clin-
ical strains of Staphylococcus epidermidis. Combination of
SNPs and gentamicin leads to synergistic decrease of genta-
micin and SNPs concentrations. Figure 3 presents typical
bacterial growth pattern in the presence of gentamicin and
SNPs. Increase in gentamicin concentration resulted in
a decrease of SNPs concentration necessary for bacterial
growth inhibition and vice versa. Minimal FIC index for
each bacterial strain identified the point where synergistic
effect was the most prominent, establishing conditions of
optimal concentrations of gentamicin and SNPs. Minimal
inhibitory concentration for gentamicin and silver nanoparti-
cles at minimal FIC index for all clinical strains are presented
in Table 1. At minimal value of FIC index, MIC of gentami-
cin was significantly decreased (median 16 times).
Simultaneously in the presence of gentamicin, bactericidal
activity of SNPs was observed. Silver nanoparticles alone did
not exhibit antimicrobial activity at a concentration of 1400
µg/mL of silver (or 60 nM of SNPs concentration). In the
presence of gentamicin, at minimal FIC index value, median
value of inhibitory concentrations of SNPs was 175 µg/mL.
Generation of ROS in the Presence of
Gentamicin
To assess the production of reactive oxygen species in the
presence of SNPs and gentamicin, the chemiluminescence
Figure 1 Differences in stability of citrate and Tween-stabilized silver nanoparticles
in bacterial growth medium.
Notes: (A) UV-Vis spectrum of citrate-stabilized silver nanoparticles before and
after addition of Mueller-Hinton Broth II medium. Metallic silver precipitation is
accompanied by suppression of characteristic nanoparticle-associated plasmon
resonance spectrum; (B) UV-Vis spectrum of Tween-stabilized silver nanoparticles
before and after addition of Mueller-Hinton Broth II medium. Strong plasmon
resonance absorption band in the range of 400 nm confirms the presence of native
metal nanoparticles.
Abbreviations: MHB II, Mueller-Hinton Broth II; SNPs, silver nanoparticles
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of luminol was tested. Addition of Tween-stabilized silver
nanoparticles to luminol-based detection system stimu-
lated production of reactive oxygen species. Consecutive
addition of gentamicin significantly increased the genera-
tion of ROS (Figure 4). The generation of ROS induced by
gentamicin decreased with time and further addition of
gentamicin did not stimulate chemiluminescence, indicat-
ing that oxidizing potential of that system is SNPs depen-
dent (Figure 5).
Discussion
Silver nanoparticles are increasingly used in various fields of
medicine and biotechnology.28 SNPs with controlled size and
shapes determined by synthesis conditions, are used in bio-
chemical diagnostics systems, bioimaging strategies, photo-
therapy of cancer cells and drugs delivery. Antibacterial
properties of silver were observed from ancient times.
Extraordinary antibacterial activity of functionalized SNPs
acquire increasing interest in 21st century.29,30
The new resistance mechanisms developed by bacteria
limited the amount of available medicines used in therapy.
Bacterial strains isolated from patients are increasingly char-
acterized by resistance to more than one group of antibiotics.
These multidrug-resistant bacterial strains are a serious chal-
lenge for health care.31 Searching for new antibacterial agents
became one of main goals of modern medicine.32 Promising
results were obtained with metal nanoparticles, including
silver nanoparticles. There are many studies evaluating anti-
microbial activity of silver nanoparticles. Silver nanoparticles
are applied on the surface of surgical instruments, implants,
catheters and dental prostheses to inhibit their microbiological
colonization.33,34 The main advantages of silver nanoparticles
used as a antimicrobial agents are: gradual release of silver
ions (which provides long-term activity), low toxicity to
eukaryotic cells (lower than silver ions) and lack of mechan-
ism of resistance developed by bacteria.35,36
The bactericidal activity of silver nanoparticles and the
mechanisms of bactericidal action raise a lot of contro-
versy. The results of published studies conducted to eluci-
date the antibacterial activity of silver nanoparticles differ
significantly.37 It is very difficult to draw specific conclu-
sions, as the published studies utilized various methods of
nanoparticle synthesis, including so called green methods,
based on undefined extract of natural products, and tested
the variety of bacterial strains and various methods for
assessing biocidal activity.38,39
The exact mechanism of bactericidal activity of silver
nanoparticles has not been fully determined.40,41 The pos-
sible modes of action of metal nanoparticles include: (a)
production of reactive oxygen species inside microbial
cells including inhibition of microbial proteins/enzymes
by increased production of H2O2. This mechanism is sup-
ported by the lack of many antioxidant mechanisms in
bacterial cells as compared to eukaryotic cells; (b) disrup-
tion of vital enzymes in bacterial respiratory chain via
forming silver complexes with electron donors containing
sulfur, oxygen, nitrogen or thiols, (c) damage of biomole-
cules such as DNA or proteins, (d) targeting the bacterial
membrane by SNPs. The accumulation of metal ions in
microbial membranes alters the bacterial membrane poten-
tial and increases the cell membrane permeability; (e)
Figure 2 Differences in stability of citrate and Tween-stabilized silver nanoparticles
in the presence of gentamicin (0.4 mg/mL).
Notes: (A) UV-Vis spectrum of citrate-stabilized silver nanoparticles before and
after addition of gentamicin (0.4 mg/mL). Metallic silver precipitation is accompanied
by suppression of characteristic nanoparticle-associated plasmon resonance spec-
trum; (B) UV-Vis spectrum of Tween-stabilized silver nanoparticles before and after
addition of gentamicin (0.4 mg/mL). Strong plasmon resonance absorption band in
the range of 400 nm confirms the presence of native metal nanoparticles.
Abbreviation: SNPs, silver nanoparticles
Dovepress Mazur et al
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electrostatic attraction between metal nanoparticles and
microbial cells which disrupt metabolic activities.42–44
In order to be used in therapy, compounds with bacterici-
dal activity must exhibit not only high biocidal activity but
also should be safe for human cells. Many of antibiotics are
highly toxic to the patient. Gentamicin, an aminoglycoside
antibiotic that exhibits bactericidal activity against aerobic
bacteria commonly used to treat respiratory and urinary tract
infections, skin and eyes diseases, causes a variety of undesir-
able side effects.45 Nephrotoxicity, neurotoxicity, ototoxicity,
Figure 3 Bacterial growth pattern in the presence of gentamicin and silver nanoparticles.
Notes: (A) Growth pattern of S.epidermidis K/8605/12 in the presence of gentamicin and SNPs. The dilutions of gentamicin (in range of 0.97 to 250 μg/mL) were made from
left to the right side of the plate, dilutions of SNPs (in range of 21.5 to 1400 μg/mL) were made from upper to lower rows of the plate. The FIC index was established on the
growth inhibition border. Minimal FIC index (0.12) identified the point where synergistic effect was the most prominent*. For each well, optical density (mean from duplicate
measurements) were presented. (B)Photography of the growth of the presented strain of Staphylococcus epidermidis K/8605/12.
Abbreviations: FIC, fractional inhibitory concentration; SNPs, silver nanoparticles
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hematological disorders and impairment of liver function are
among of the most deteriorating effects. One of the main
problems of pharmacology is to use therapeutic compounds
in the lowest possible doses, as well as to search for alternative
therapeutic agents with similar efficacy but less toxicity.46
Gentamicin is a part of the basic panel of susceptibility testing
for Staphylococcus epidermidis strains isolated from blood.
Staphylococcus epidermidis is the most common coagulase-
negative staphylococci responsible for nosocomial infections
observed among newborns with very low birth weight and
associated with colonization of medical devices. Research
conducted at intensive care units in Poland showed that 95%
of Staphylococcus epidermidis strains isolated from blood of
neonates with very low birth weight were resistant to
gentamicin.47 In treatment of Staphylococcus epidermidis
infections, gentamicin is very often used in combination
with other antibiotics.
The effect of silver nanoparticles on human cells is not
entirely known. The small diameter and surface of the nano-
particles enables to their transport with blood to all organs
and tissues.48,49 Research has been done to assess the toxic
activity of silver nanoparticles.50,51 It is not entirely clear
whether the nanoparticles themselves are responsible for
their toxic activity, or whether the silver ions that are gradu-
ally released contribute to the toxic effect.52,53 The effect of
silver nanoparticles on human cells is similar to their effect
on bacterial cells. They change the structure of the cell wall,
affect the process of protein synthesis and reduce the poten-
tial of the mitochondrial membrane.54–56, Questionable
safety of SNPs enforces administrating of silver nanoparti-
cles in the lowest possible concentrations. To achieve this
effect, various methods of stabilizing and functionalizing the
surface of silver nanoparticles are sought, as well as their
combinations with other agents with bactericidal activity. All
this technological solutions contribute to the increase in the
bactericidal activity of nanoparticles, while reducing their
concentration.57,58 Our study utilized relatively high concen-
trations of SNPs. However, such concentrations might be
used eg in preparations designed for external use, such as
ointments. This is clinically relevant, as gentamicin is one of
the antibiotics used externally to treat skin infections. It is
noteworthy that the synthesis of SNPs is relatively inexpen-
sive, broadening their universal use.
To achieve bactericidal effect, nanoparticles must be stable
and active in the complex microbiological media.59 Despite
the fact that citrate-stabilized silver nanoparticles are widely
used, their lack of stability in a complex microbiological
environment excludes the possibility of their use in microbio-
logical tests. The stability of nanoparticles can be achieved by
using various types of ionic and non-ionic factors (polymers
and surfactants).17,60 SNPs must also be stable in the presence
of other compounds as antibiotics. Tween 80 ensures the
stability of silver nanoparticles in a microbiological medium
and in the presence of positively charged antibiotics, including
gentamicin. Similar effect in stabilization of silver nanoparti-
cles with Tween 80 was reported by Chen et al. For several
tested surfactants, the most preferable effect was achieved
with using Tween 80-stabilized silver nanoparticles, which
have been recognized by the authors as a very promising
antibacterial agent.61
In this study, the antibacterial activity of silver nano-
particles combined with gentamicin was investigated.













K/8605/12 MRSE, MLSB 500 31.25 87 16 0.12
K/4042/16 MRSE, MLSB 500 31.25 175 16 0.19
K/8399/12 MRSE, MLSB 500 31.25 175 16 0.19
K/15/928 MRSE, MLSB 500 7.81 87 64 0.08
K/15/323 MRSE 125 0.97 350 128 0.26
K/15/534 MRSE, MLSB 250 31.25 87 16 0.18
K/15/428 MRSE, MLSB 500 62.5 175 8 0.25
K/15/420 MRSE, MLSB 500 31.25 87 16 0.13
K/16/3882 MRSE, MLSB 500 31.25 175 16 0.19
Note: Minimal inhibitory concentrations for gentamicin and silver nanoparticles and minimal FIC index for all clinical strains of Staphylococcus epidermidis.
Abbreviations: FIC, fractional inhibitory concentration; MIC, minimal inhibitory concentration; MLSB, macrolide-lincosamide-streptogramin resistance of Staphylococcus
epidermidis; MRSE, methicillin-resistant Staphylococcus epidermidis; SNPs, silver nanoparticles.
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Other studies on the mechanism of action of the nanopar-
ticles-antibiotic combinations have suggested that the
improvement in the antimicrobial activity could be caused
by their chemical interaction. The underlying molecular
mechanism of the effect, either synergistic or additive, still
requires clarification.62,63 In former studies, it was postu-
lated that combinatorial effect of antimicrobials drives
synergy by membrane alterations generated by SNPs and
no chemical interactions between SNPs and antibiotics
were detected.64 We demonstrated that synergistic
mechanism is based on direct specific chemical interac-
tions between SNPs and gentamicin stimulating produc-
tion of ROS. In our study, antimicrobial activity was
assessed against well characterized clinical strains of
Staphylococcus epidermidis with developed mechanisms
of resistance to beta-lactam antibiotics (MRSE) and to
macrolides, lincosamides and streptogramins groups of
antibiotics (MLSB). Staphylococcus epidermidis is
a species of Gram positive bacteria present on the skin
and responsible for the most of nosocomial infections
resistant to antibiotics used in the therapy.65 All clinical
strains of multidrug-resistant Staphylococcus epidermidis
were resistant to gentamicin. Eight of nine investigated
strains displayed ability to bacterial biofilm formation, an
additional virulence factor of external surface matrix con-
sisted of proteins and oligosaccharides.66
We observed no antimicrobial effects of SNPs alone
against tested strains, even at the highest concentration of
SNPs (1400 µg/mL, 60 nM of SNPs concentration). This
is in line with former evidence: the lack of significant
results in the assessment of the antibacterial properties of
weak, (citrate) stabilized silver nanoparticles against the
reference strain of Staphylococcus aureus was described
by Kin et al. There were no antimicrobial effect of silver
nanoparticles even at the highest concentration of SNPs -
33 nM.67
On the contrary, in the presence of gentamicin, silver
nanoparticles show antibacterial activity against tested
strains of S. epidermidis. The interpretation of the checker-
board method, used to assess the antimicrobial activity of
combination SNPs and gentamicin was based on the value of
Fractional Inhibitory Concentration index. The FIC value
provides information on whether the achieved bactericidal
effect is associated with the synergistic effect of the com-
pounds, or whether it can be an additive effect.24 Several
studies indicated that SNPs may enhance the antibacterial
Figure 4 Silver nanoparticles-associated generation of ROS in the presence of gentamicin.
Note: The chemiluminescence of luminol (stage 1) in the presence of Tween-stabilized silver nanoparticles (stage 2) and stabilized silver nanoparticles combined with
gentamicin (2 µL of gentamicin, the final antibiotic concentration 0.4 mg/mL) (stage 3).
Abbreviations: CL, chemiluminescence; RLU, relative luminescence units; ROS, reactive oxygen species; SNPs, silver nanoparticles.
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effects of antibiotics. However, these synergistic effects of
SNPs–antibiotic conjunction were observed against antibio-
tic susceptible bacteria. Only few studies confirmed
a successful synergistic effect of SNPs–antibiotics combina-
tions in MDR bacteria.68 The minimal value of FIC index is
associated with the most prominent conditions for bacterici-
dal effect. The combination of SNPs and gentamicin leads to
decrease in the minimal inhibitory concentration of gentami-
cin for all of tested strains of S. epidermidis. The synergistic
effect of silver nanoparticles and gentamicin against
Escherichia coli and Staphylococcus aureus strains was
reported by Wang et al.7 Authors demonstrated that the pre-
sence of gentamicin even at low concentration (1 µg/mL)
stimulates antimicrobial activity of silver nanoparticles
against reference strains. The authors explained the differ-
ences between E. coli and S. aureus susceptibility to silver
nanoparticles and gentamicin by the different membrane
structure of Gram-positive and Gram-negative bacteria.
Gram-negative Escherichia coli strains present higher sensi-
tivity to SNPs and gentamicin than Gram-positive
Staphylococcus aureus strains.
It was suggested that one of the possible mechanisms
of bactericidal activity of silver nanoparticles relies on
stimulation of production of reactive oxygen species.
Oxidative stress caused by silver nanoparticles through the
increase in ROS production leads to damage of the proteins
and nucleic acids, and consequently to inhibition of cell pro-
liferative processes.44,69
There are many works confirming that SNPs in various
conditions can produce toxic ROS including hydrogen
peroxide (H2O2), superoxide anions (O2
−), and most reac-
tive hydroxyl radicals (OH*).7,66,69 Liu et al showed that
silver nanoparticles stimulate the chemiluminescence of
luminol and the intensity of the chemiluminescence is
dependent on the size of SNPs, the most intense chemilu-
minescence was generated by the silver nanoparticles with
the smallest diameter.70 On the contrary, investigation
concerning the generation of ROS in SNPs-gentamicin
system is controversial. Some of the studies conclude
that ROS do not play a major role in the gentamicin
potentiating activity of silver.71 Some recent works have
shown the generation of ROS in the presence of silver ions
(derived from silver nitrate) and gentamicin.72
In order to determine the mechanism of the combined
antibacterial activity of silver nanoparticles and gentamicin,
our study utilized a test based on the chemiluminescence of
Figure 5 Silver nanoparticles-associated generation of ROS stimulated by subsequent doses of gentamicin.
Note: Luminol chemiluminescence in the presence of Tween-stabilized silver nanoparticles after addition of subsequent amounts of gentamicin (2µL of gentamicin, delta
concentration 0.4 mg/mL).
Abbreviations: CL, chemiluminescence; RLU, relative luminescence units; ROS, reactive oxygen species; SNPs, silver nanoparticles.
Dovepress Mazur et al
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luminol to assess the production of reactive oxygen species
both by the nanoparticles themselves and by their combina-
tion with gentamicin. In luminol model, Tween-stabilized
silver nanoparticles generated reactive oxygen species. The
presence of gentamicin significantly increased the generation
of ROS (Figure 4). Decrease in ROS production over time,
which is not stimulated by subsequent doses of gentamicin
(Figure 5) confirms that the bactericidal oxidation potential
of the system depends on silver nanoparticles.
Antibacterial effects of SNPs, either in metallic form or
in gradually released ionic form yields multifactorial sys-
tem operating on different cellular levels. That system, in
combination with antibiotics influences on many bacterial
structures and metabolic processes concurrently. In con-
nection with different forms of ROS, it is an antimicrobial
defending system characterized by low risk of bacterial
resistance development.68
Conclusion
To ensure pronounced antibacterial activity, SNPs must be
stable in complex bacteria environments. Tween-stabilized
silver nanoparticles and gentamicin revealed synergistic
antibacterial activity against multidrug-resistant strains of
Staphylococcus epidermidis. The combination of silver
nanoparticles and gentamicin allowed to decrease the
minimal inhibitory concentration of gentamicin (median
16 times). Gentamicin increased the generation of SNPs
derived ROS, one of the probable co-mechanisms of com-
plex SNPs-antibiotic system.
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